デフォルト表紙
市場調査レポート
商品コード
1617697

ヘルスケア分析検査サービス市場:サービス別、サンプルタイプ別、エンドユーザー別-2025-2030年の世界予測

Healthcare Analytical Testing Services Market by Services (Batch Release Testing Services, Bioanalytical Testing, Clinical Trials Testing), Sample Type (Biological Samples, Chemical Substances), End User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 196 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヘルスケア分析検査サービス市場:サービス別、サンプルタイプ別、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルスケア分析検査サービス市場は、2023年に48億8,000万米ドルと評価され、2024年には54億1,000万米ドルに達すると予測され、CAGR 11.34%で成長し、2030年には103億6,000万米ドルに達すると予測されています。

ヘルスケア分析検査サービスには、医薬品、生物製剤、医療機器などのヘルスケア製品の安全性、有効性、品質を確保するために不可欠な、さまざまな専門的検査サービスが含まれています。これらのサービスの必要性は、ヘルスケア製品が市場に出回る前に必要な基準を満たしていることを保証するために、徹底的な試験とバリデーションが義務付けられている厳しい規制環境に起因しています。分析試験サービスの応用は、初期の研究開発から臨床試験、最終的には商品化まで、製品開発のさまざまな段階に及ぶ。エンドユーザーには主に製薬会社、バイオ製薬会社、医療機器メーカー、医薬品開発業務受託機関(CRO)が含まれます。

主な市場の統計
基準年[2023] 48億8,000万米ドル
推定年[2024] 54億1,000万米ドル
予測年[2030] 103億6,000万米ドル
CAGR(%) 11.34%

医薬品や個別化医療の複雑化に伴い、高度な検査手法が必要とされるようになったことが、調査手法市場を大きく牽引しています。特筆すべき成長要因は、分析試験サービスのアウトソーシング動向の高まりであり、これにより企業は専門サービスプロバイダーの専門知識を活用しながらコアコンピタンスに集中することができます。さらに、分析技術の進歩やバイオシミラーおよび生物製剤の採用拡大も、大きな成長機会をもたらしています。しかし、厳格な規制遵守、高度な検査技術に関連する高コスト、複雑な生物製剤検査に関連する技術的困難などの課題は、依然として潜在的な成長阻害要因となっています。

自動化されたハイスループット試験プラットフォームの開発における研究開発と、データ解析のための人工知能(AI)は、事業成長の大きな可能性を秘めた道です。業界各社が世界なプレゼンス拡大を目指す中、地域施設への投資や現地の専門知識の活用は推奨される戦略です。市場競争は激しいが、差別化されたサービスの提供や戦略的パートナーシップは、競争優位の道となります。また、精密医療やバイオマーカー探索検査におけるイノベーションを模索することも可能です。分析サービスに持続可能なグリーンケミストリーを採用すれば、さらに長期的な利益をもたらし、環境意識の高い利害関係者にアピールすることができます。

市場力学:急速に進化するヘルスケア分析検査サービス市場の主要市場インサイトを公開

ヘルスケア分析検査サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • ヘルスケア分野における分析試験アウトソーシング需要の高まり
    • バイオ医薬品と医療機器の継続的な進歩
    • ヘルスケア分野における公的支出および民間支出の増加
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • AIや機械学習を含む先端技術の統合
    • 迅速検査法と個別化医療アプローチの開発
  • 市場の課題
    • 世界的に厳しい規制基準

ポーターのファイブフォース:ヘルスケア分析検査サービス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:ヘルスケア分析検査サービス市場における外部からの影響の把握

外部マクロ環境要因は、ヘルスケア分析検査サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘルスケア分析検査サービス市場における競合情勢の把握

ヘルスケア分析検査サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘルスケア分析検査サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘルスケア分析検査サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘルスケア分析検査サービス市場における成功への道筋を描く

ヘルスケア分析検査サービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ヘルスケア分野における分析試験アウトソーシングの需要増加
      • バイオ医薬品と医療機器の継続的な進歩
      • ヘルスケア分野における公的および民間支出の増加
    • 抑制要因
      • 高度なスキルを持つ専門家の不足
    • 機会
      • AIや機械学習などの先進技術の統合
      • 迅速検査法と個別化医療アプローチの開発
    • 課題
      • 世界中で厳しい規制基準
  • 市場セグメンテーション分析
    • サービス:ヘルスケア分野における必須の試験サービス、医薬品の品質と環境の安全性の確保
    • エンドユーザー:ヘルスケアと医薬品開発における分析試験の重要な役割、安全性と効率性の確保
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 ヘルスケア分析検査サービス市場:サービス別

  • バッチリリーステストサービス
  • 生体分析試験
  • 臨床試験テスト
  • 環境モニタリング

第7章 ヘルスケア分析検査サービス市場サンプルタイプ別

  • 生物学的サンプル
  • 化学物質

第8章 ヘルスケア分析検査サービス市場:エンドユーザー別

  • 臨床調査機関
  • 医療機器企業
  • 製薬・バイオ医薬品企業

第9章 南北アメリカのヘルスケア分析検査サービス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のヘルスケア分析検査サービス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのヘルスケア分析検査サービス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • LGM Pharmaによる分析試験および製造能力の強化
    • Kindevaドラッグデリバリーが分析サービスを強化し、医薬品および医療機器分野における世界な能力を向上
    • ミリポアシグマがライフサイエンスの品質試験に革命を起こすChemisTwinを発売
  • 戦略分析と提言

企業一覧

  • Almac Group Limited
  • ALS Limited
  • Catalent, Inc.
  • CD Biosciences Inc.
  • Charles River Laboratories, Inc.
  • Element Materials Technology Group Limited
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc. by Tigermed
  • ICON PLC
  • Intertek Group PLC
  • IQVIA, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • Merck KGaA
  • Pace Analytical Services, LLC
  • Piramal Pharma Solutions
  • PPD, Inc.
  • Reading Scientific Services Ltd.
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
図表

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BATCH RELEASE TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL TRIALS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL SUBSTANCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-F949FCDE0EC4

The Healthcare Analytical Testing Services Market was valued at USD 4.88 billion in 2023, expected to reach USD 5.41 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 10.36 billion by 2030.

Healthcare Analytical Testing Services encompass a range of specialized laboratory services that are essential for ensuring the safety, efficacy, and quality of healthcare products, including pharmaceuticals, biologics, and medical devices. The necessity of these services stems from the stringent regulatory environment that mandates thorough testing and validation to ensure that healthcare products meet the required standards before reaching the market. The application of analytical testing services spans various stages of product development, from early research and development to clinical trials, and ultimately to commercialization. End-users primarily include pharmaceutical and biopharmaceutical companies, medical device manufacturers, and contract research organizations (CROs).

KEY MARKET STATISTICS
Base Year [2023] USD 4.88 billion
Estimated Year [2024] USD 5.41 billion
Forecast Year [2030] USD 10.36 billion
CAGR (%) 11.34%

The market for healthcare analytical testing services is being significantly driven by the increasing complexity of pharmaceutical products and personalized medicine, which necessitate sophisticated testing methodologies. A notable growth driver is the rising trend in outsourcing analytical testing services, which enables companies to focus on their core competencies while leveraging the expertise of specialized service providers. Additionally, advancements in analytical technologies and the increasing adoption of biosimilars and biologics provide substantial growth opportunities. However, challenges such as strict regulatory compliance, high costs associated with advanced testing techniques, and technical difficulties related to complex biologics testing remain potential growth deterrents.

Innovation and research in the development of automated and high-throughput testing platforms, and artificial intelligence (AI) for data analysis are avenues with immense potential for business growth. As industry players look toward expanding their global presence, investment in regional facilities and leveraging local expertise are recommended strategies. Despite the competitive nature of the market, differentiated service offerings and strategic partnerships provide avenues for competitive advantage. Companies could also explore innovation in precision medicine and biomarker discovery testing, as these areas are set to see burgeoning demand. Adopting sustainable and green chemistry practices in analytical services can further yield long-term benefits and appeal to environmentally-conscious stakeholders.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Analytical Testing Services Market

The Healthcare Analytical Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for analytical testing outsourcing in healthcare sector
    • Ongoing advances in biopharmaceuticals and medical devices
    • Rising public and private expenditure in healthcare sector
  • Market Restraints
    • Lack of highly skilled professionals
  • Market Opportunities
    • Integration of advanced technologies including AI and machine learning
    • Development of rapid testing methods and personalized medicine approach
  • Market Challenges
    • Stringent regulatory standards worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Analytical Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Analytical Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Analytical Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Analytical Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Analytical Testing Services Market

A detailed market share analysis in the Healthcare Analytical Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Analytical Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Analytical Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Analytical Testing Services Market

A strategic analysis of the Healthcare Analytical Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Analytical Testing Services Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, ALS Limited, Catalent, Inc., CD Biosciences Inc., Charles River Laboratories, Inc., Element Materials Technology Group Limited, Eurofins Scientific SE, Frontage Laboratories, Inc. by Tigermed, ICON PLC, Intertek Group PLC, IQVIA, Inc., Laboratory Corporation of America Holdings, Medpace, Inc., Merck KGaA, Pace Analytical Services, LLC, Piramal Pharma Solutions, PPD, Inc., Reading Scientific Services Ltd., Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Analytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Batch Release Testing Services, Bioanalytical Testing, Clinical Trials Testing, and Environmental Monitoring.
  • Based on Sample Type, market is studied across Biological Samples and Chemical Substances.
  • Based on End User, market is studied across Clinical Research Organizations, Medical Device Companies, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for analytical testing outsourcing in healthcare sector
      • 5.1.1.2. Ongoing advances in biopharmaceuticals and medical devices
      • 5.1.1.3. Rising public and private expenditure in healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of highly skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies including AI and machine learning
      • 5.1.3.2. Development of rapid testing methods and personalized medicine approach
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory standards worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Essential Testing Services in Healthcare Sector, Safeguarding Drug Quality and Environmental Safety
    • 5.2.2. End User: Crucial Role of Analytical Testing in Healthcare and Pharmaceutical Development, Ensuring Safety and Efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Analytical Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Batch Release Testing Services
  • 6.3. Bioanalytical Testing
  • 6.4. Clinical Trials Testing
  • 6.5. Environmental Monitoring

7. Healthcare Analytical Testing Services Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Samples
  • 7.3. Chemical Substances

8. Healthcare Analytical Testing Services Market, by End User

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Healthcare Analytical Testing Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Healthcare Analytical Testing Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Healthcare Analytical Testing Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Enhancing Analytical Testing and Manufacturing Capabilities by LGM Pharma
    • 12.3.2. Kindeva Drug Delivery Bolsters Analytical Services, Enhancing Global Capabilities in Pharmaceutical and Medical Device Sectors
    • 12.3.3. Launch of ChemisTwin by MilliporeSigma, Revolutionizing Quality Testing in Life Sciences
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group Limited
  • 2. ALS Limited
  • 3. Catalent, Inc.
  • 4. CD Biosciences Inc.
  • 5. Charles River Laboratories, Inc.
  • 6. Element Materials Technology Group Limited
  • 7. Eurofins Scientific SE
  • 8. Frontage Laboratories, Inc. by Tigermed
  • 9. ICON PLC
  • 10. Intertek Group PLC
  • 11. IQVIA, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. Medpace, Inc.
  • 14. Merck KGaA
  • 15. Pace Analytical Services, LLC
  • 16. Piramal Pharma Solutions
  • 17. PPD, Inc.
  • 18. Reading Scientific Services Ltd.
  • 19. Sartorius AG
  • 20. SGS SA
  • 21. Thermo Fisher Scientific Inc.
  • 22. WuXi AppTec